Post by Vi
13,112 followers
Spencer Honeyman on how Vi helped accelerate a Phase 3 rare disease trial by 72% — pulling the timeline up nine months and getting patients on therapy sooner.
Video Content
13,112 followers
Spencer Honeyman on how Vi helped accelerate a Phase 3 rare disease trial by 72% — pulling the timeline up nine months and getting patients on therapy sooner.
Video Content